Form 4: HealthEquity CCO Gathright Receives RSU Grant

HealthEquity's Chief Customer Officer, Michael Gathright, was granted 15,157 restricted stock units, aligning his interests with shareholders.

Summary

• Michael Gathright, Chief Customer Officer of HealthEquity, Inc. (HQY), acquired 15,157 shares of common stock in the form of restricted stock units (RSUs).
• The transaction date for this acquisition was March 25, 2026.
• Following this transaction, Michael Gathright beneficially owns 42,163 shares directly.
• Each restricted stock unit represents a contingent right to receive one share of HealthEquity's common stock.
• The shares will vest in a staggered schedule: 25% of the initial award vests on April 1, 2027, and then 6.25% vests on the first day of each calendar quarter for the subsequent twelve calendar quarters.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive alignment with shareholder interests through equity compensation, which is a standard and healthy corporate governance practice.

Positives

• The grant of restricted stock units to a key executive like the Chief Customer Officer aligns management's long-term interests with those of the company's shareholders, incentivizing performance and retention.
• The vesting schedule, extending over several years, encourages sustained commitment and performance from the executive.

Future Outlook

The filing details a future vesting schedule for restricted stock units, indicating a long-term incentive structure for the Chief Customer Officer, with shares vesting quarterly through 2030.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units to executives is a common practice across industries, particularly in technology and healthcare sectors, to attract, retain, and motivate key talent. This type of equity compensation is designed to align executive performance with shareholder value creation over the long term. Competitors often utilize similar compensation structures to ensure executive commitment.

Comparison to Industry Standards

• The use of restricted stock units with a multi-year vesting schedule is a standard practice for executive compensation in publicly traded companies, comparable to incentive programs at firms like Optum, CVS Health, or Fidelity, which also operate in the health and financial services sectors.
• The size of the grant, 15,157 RSUs, is within typical ranges for a Chief Customer Officer at a company of HealthEquity's market capitalization, reflecting a balance between incentive and dilution.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Chief Customer Officer's financial interests with long-term shareholder value creation, potentially leading to improved company performance and stock appreciation.
• Employees: This type of executive compensation can signal stability and a commitment to retaining key leadership, which can positively influence overall employee morale and retention.

Next Steps

• The restricted stock units will begin vesting on April 1, 2027, with 25% of the initial award.
• Subsequent vesting will occur at 6.25% on the first day of each calendar quarter for the twelve quarters following April 1, 2027.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (RSU grant) and does not contain information significant enough to warrant a change in investment recommendation. It primarily indicates ongoing executive alignment with company performance, which is generally a positive but not a catalyst for a strong buy or sell decision on its own.

Keywords

HealthEquity, HQY, Michael Gathright, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Stock Grant, Form 4, Beneficial Ownership